JPH0548227B2 - - Google Patents
Info
- Publication number
- JPH0548227B2 JPH0548227B2 JP14601884A JP14601884A JPH0548227B2 JP H0548227 B2 JPH0548227 B2 JP H0548227B2 JP 14601884 A JP14601884 A JP 14601884A JP 14601884 A JP14601884 A JP 14601884A JP H0548227 B2 JPH0548227 B2 JP H0548227B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- acid
- hydantoin
- present
- alkylidenehydantoin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002576 ketones Chemical class 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 6
- 229940091173 hydantoin Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- GHKHZJHMIBYCPG-UHFFFAOYSA-N 5-propan-2-ylideneimidazolidine-2,4-dione Chemical compound CC(C)=C1NC(=O)NC1=O GHKHZJHMIBYCPG-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- -1 alkali metal salts Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000001469 hydantoins Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- SAJFNBFKWLDJBX-UHFFFAOYSA-N 5-butan-2-ylideneimidazolidine-2,4-dione Chemical compound CCC(C)=C1NC(=O)NC1=O SAJFNBFKWLDJBX-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- UEKDRLRXXAOOFP-UHFFFAOYSA-N imidazolidine-2,4-dione Chemical compound O=C1CNC(=O)N1.O=C1CNC(=O)N1 UEKDRLRXXAOOFP-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Description
【発明の詳細な説明】
イ 産業上の利用分野
本発明は、式(1)
(ここにR1、R2は異なつても同一でも良くC1〜4
のアルキル基を示す)で表わされる5−アルキリ
デンヒダントインの製造方法に関するものであ
る。上記5−アルキリデンヒダントインは医薬品
として注目されている。α−ケトカルボン酸や、
アミノ酸を製造するための重要な中間体である。[Detailed Description of the Invention] A. Field of Industrial Application The present invention is based on the formula (1) (Here, R 1 and R 2 may be different or the same, and C 1 to 4
The present invention relates to a method for producing 5-alkylidenehydantoin represented by the following alkyl group. The above-mentioned 5-alkylidenehydantoin is attracting attention as a pharmaceutical product. α-ketocarboxylic acid,
It is an important intermediate for producing amino acids.
ロ 従来の技術
カルボニル化合物とヒダントイン類を縮合させ
て5−置換ヒダントイン類を得る方法は公知であ
るが、それらのほとんどは、アルデヒド類との反
応であつて、ケトン類との反応例は少ない。更
に、これらの公知の方法では、反応は酢酸溶媒中
で行なわれたり(J.Am.Chem.Soc.、45、369
(1911))、無水ピペラジン中で行なわれ(Org.
Syn.Coll.Vol.、5、627)るなど、いずれも高価
な有機溶媒を使用しており、工業的に満足すべき
ものではない。B. Prior Art Methods for obtaining 5-substituted hydantoins by condensing carbonyl compounds with hydantoins are known, but most of them involve reactions with aldehydes, and there are only a few examples of reactions with ketones. Furthermore, in these known methods, the reaction is carried out in an acetic acid solvent (J.Am.Chem.Soc., 45 , 369
(1911)) in anhydrous piperazine (Org.
Syn.Coll.Vol., 5 , 627), all of which use expensive organic solvents and are not industrially satisfactory.
ハ 問題点を解決するための手段及び発明の効果
本発明は式(2)
(ここにR1、R2は異なつても同一でも良く、
C1〜4のアルキル基を示す)で表わされるケトンを
アミノ酸又は、その塩の存在下、PH8〜12の範囲
の水又は水性溶液中でヒダントイン(2,4−イ
ミダゾリジンジオン)と反応させることにより、
工業的に遊離に5−アルキリデンヒダントインを
製造する方法を提供するものである。本発明によ
れば、水系の溶媒中で、比較的短かい反応時間内
に結晶性の良い5−アルキリデンヒダントインを
好収率で得ることができる。C Means for solving the problems and effects of the invention The present invention is based on the formula (2) (Here, R 1 and R 2 may be different or the same,
Reacting a ketone represented by (representing a C1-4 alkyl group) with hydantoin (2,4-imidazolidinedione) in the presence of an amino acid or a salt thereof in water or an aqueous solution in the pH range of 8 to 12. According to
The present invention provides a method for industrially producing 5-alkylidenehydantoin in free form. According to the present invention, 5-alkylidenehydantoin with good crystallinity can be obtained in a good yield within a relatively short reaction time in an aqueous solvent.
本発明の原料であるケトンは、具体的には、ア
セトン、メチルエチルケトン、ジエチルケトン、
メチルプロピルケトン、メチルイソプロピルケト
ン、メチルブチルケトン、メチルイソブチルケト
ンなどである。 Specifically, the ketones that are raw materials of the present invention include acetone, methyl ethyl ketone, diethyl ketone,
These include methylpropylketone, methylisopropylketone, methylbutylketone, and methylisobutylketone.
本発明で使用される反応溶媒としては、一般に
水が用いられるが、水のみならず、必要に応じて
メタノール、エタノール、ジオキサンなどの水に
可溶な有機溶媒を水と混合したものを使用するこ
ともできる。 Water is generally used as the reaction solvent in the present invention, but not only water but also a mixture of water and a water-soluble organic solvent such as methanol, ethanol, dioxane, etc. may be used as necessary. You can also do that.
使用するアミノ酸としては、グルタミン酸、ア
スパラギン酸、リジン、アルギニン、オルニチ
ン、グリシン、α−アラニン、ロイシン、イソロ
イシン、バリン、β−アラニン、フエニルアラニ
ン、チロシン、ドーパ、フエニルグリシン、セリ
ン、スレオニン、メチオニン、タウリンなど及び
その塩をそれら単独でも、またはそれらのいくく
つかを混合して使用できる。塩の形としては、ナ
トリウム塩、カリウム塩などのアルカリ金属塩、
カルシウム塩などのアルカリ土類金属塩、および
塩酸塩、硫酸塩などの鉱酸塩が使用できる。また
使用量はヒダントインに対して0.1〜2モル比、
好ましくは、0.3〜1モル比が良い。少ないと効
果が少なくまたは多く使用しても、それに見合う
効果は得られず経済的でない。 Amino acids used include glutamic acid, aspartic acid, lysine, arginine, ornithine, glycine, α-alanine, leucine, isoleucine, valine, β-alanine, phenylalanine, tyrosine, dopa, phenylglycine, serine, threonine, and methionine. , taurine, etc., and their salts can be used alone or in combination. Salt forms include alkali metal salts such as sodium salts and potassium salts,
Alkaline earth metal salts such as calcium salts and mineral acid salts such as hydrochlorides and sulfates can be used. In addition, the amount used is 0.1 to 2 molar ratio to hydantoin,
Preferably, the molar ratio is 0.3 to 1. If it is used too little, the effect will be low, and even if it is used too much, the corresponding effect will not be obtained and it is not economical.
反応時のPHは8〜12、好ましくは9〜10が良
い。アミノ酸を中性ないし酸性で使用しても効果
は得られず、上記PHに反応液PHを調製する必要が
ある。PHの調製に使用するアルカリの種類として
は、水酸化ナトリウム、水酸化カリウム、炭酸ナ
トリウム、炭酸カリウムなどのアルカリ金属水酸
化物およびそれらの炭酸塩、水酸化マグネシウ
ム、水酸化カルシウム等のアルカリ土類金属水酸
化物等が使用できる。PH調製に酸を使用する場合
は、塩酸、硫酸などの鉱酸及びギ酸、酢酸などの
有機酸が使用できる。 The pH during the reaction is preferably 8 to 12, preferably 9 to 10. Even if the amino acid is used in a neutral or acidic state, no effect is obtained, and it is necessary to adjust the pH of the reaction solution to the above-mentioned pH. Types of alkali used for pH preparation include alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, sodium carbonate, and potassium carbonate, and their carbonates, and alkaline earth metals such as magnesium hydroxide and calcium hydroxide. Metal hydroxides etc. can be used. When using acids for pH adjustment, mineral acids such as hydrochloric acid and sulfuric acid and organic acids such as formic acid and acetic acid can be used.
反応温度及び時間については必ずしも厳密な制
限はないが、通常は40〜100℃好ましくは60〜80
℃であり、1〜10時間、好ましくは2〜5時間で
ある。 There are no strict restrictions on the reaction temperature and time, but it is usually 40-100°C, preferably 60-80°C.
°C for 1 to 10 hours, preferably 2 to 5 hours.
反応生成物である5−アルキリデンヒダントイ
ンは水に難溶性であるので、反応の進行と共に結
晶として析出するので遠心分離等の方法により、
容易に分離回収することができる。 Since the reaction product 5-alkylidenehydantoin is sparingly soluble in water, it precipitates as crystals as the reaction progresses, so it can be removed by centrifugation or other methods.
It can be easily separated and recovered.
ニ 実施例
以下実施例によつて、本発明の方法について更
に具体的に説明する。但し、これらは説明のため
の単なる例示であり、本発明はこれらの例に何ら
制限されない。D. Examples The method of the present invention will be explained in more detail with reference to Examples below. However, these are merely examples for explanation, and the present invention is not limited to these examples in any way.
実施例 1
温度計、還流冷却器、撹拌機を備えた500mlセ
パラブルフラスコを恒温槽中にセツトした。Example 1 A 500 ml separable flask equipped with a thermometer, reflux condenser, and stirrer was set in a constant temperature bath.
水200ml、ヒダントイン50.0g(=0.50mol)、
アセトン58.0g(=1.00mol)、グリシン37.5g
(=0.50mol)、カセイソーダ10.0g(=0.25mol)
を入れ、昇温し60〜65℃にて6時間撹拌した。こ
の間反応液のPHは9.8〜9.6であつた。室温まで冷
却後遠心分離により結晶を回収して、5−イソプ
ロピリデンヒダントイン64.5gを得た。ヒダント
インに対して、92.1%の収率であつた。 200ml of water, 50.0g of hydantoin (=0.50mol),
Acetone 58.0g (=1.00mol), glycine 37.5g
(=0.50mol), caustic soda 10.0g (=0.25mol)
was added, the temperature was raised, and the mixture was stirred at 60 to 65°C for 6 hours. During this time, the pH of the reaction solution was 9.8 to 9.6. After cooling to room temperature, the crystals were collected by centrifugation to obtain 64.5 g of 5-isopropylidenehydantoin. The yield was 92.1% based on hydantoin.
実施例 2
実施例1において、グリシンをアラニン44.5g
(=0.50mol)にアセトンをメチルエチルケトン
108.3g(=1.50mol)にかえて、75〜80℃にて6
時間撹拌した。この間、反応液のPHは9.7〜9.5で
あつた。室温まで冷却後、遠心分離により結晶を
回収して、5−セカンダリ−ブチリデンヒダント
イン57.8gを得た。ヒダントインに対して75%の
収率であつた。Example 2 In Example 1, 44.5g of alanine was substituted for glycine.
(=0.50mol) of acetone and methyl ethyl ketone
6 at 75-80℃ instead of 108.3g (=1.50mol)
Stir for hours. During this time, the pH of the reaction solution was 9.7 to 9.5. After cooling to room temperature, the crystals were collected by centrifugation to obtain 57.8 g of 5-secondary-butylidenehydantoin. The yield was 75% based on hydantoin.
比較例 1
実施例1においてカセイソーダを33.0g使用し
て同様に反応させた。この間、反応液のPHは12.8
〜12.0であつた。冷却後、遠心分離して5−イソ
プロピリデンヒダントイン17.0gを得た。ヒダン
トインに対して24.3%の収率であつた。Comparative Example 1 The same reaction as in Example 1 was carried out using 33.0 g of caustic soda. During this time, the pH of the reaction solution was 12.8.
It was ~12.0. After cooling, it was centrifuged to obtain 17.0 g of 5-isopropylidenehydantoin. The yield was 24.3% based on hydantoin.
比較例 2
実施例1においてカセイソーダを2.1g使用し
て、同様に反応させた。この間反応液のPHは7.5
〜6.8であつた。冷却後、遠心分離して5−イソ
プロピリデンヒダントイン7.5gを得た。ヒダン
トインに対して10.7%の収率であつた。Comparative Example 2 2.1g of caustic soda was used in Example 1, and the reaction was carried out in the same manner as in Example 1. During this time, the pH of the reaction solution was 7.5.
It was ~6.8. After cooling, it was centrifuged to obtain 7.5 g of 5-isopropylidenehydantoin. The yield was 10.7% based on hydantoin.
Claims (1)
のアルキル基を示す)で表わされるケトンを、ア
ミノ酸又はその塩の存在下PH8〜12の範囲の水又
は水性溶液中でヒダントインと反応させることを
特徴とする式 (ここにR1、R2は前記のとおり)で表わされる
アルキリデンヒダントイン類の製造法。[Claims] 1 formula (Here, R 1 and R 2 may be different or the same, and C 1 to 4
A formula characterized by reacting a ketone represented by (representing an alkyl group of A method for producing an alkylidenehydantoin represented by (wherein R 1 and R 2 are as described above).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14601884A JPS6127970A (en) | 1984-07-16 | 1984-07-16 | Preparation of 5-alkylidenehydantoin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14601884A JPS6127970A (en) | 1984-07-16 | 1984-07-16 | Preparation of 5-alkylidenehydantoin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6127970A JPS6127970A (en) | 1986-02-07 |
JPH0548227B2 true JPH0548227B2 (en) | 1993-07-20 |
Family
ID=15398231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14601884A Granted JPS6127970A (en) | 1984-07-16 | 1984-07-16 | Preparation of 5-alkylidenehydantoin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6127970A (en) |
-
1984
- 1984-07-16 JP JP14601884A patent/JPS6127970A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6127970A (en) | 1986-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6472380B1 (en) | Glucosamine sulfate calcium chloride composition and processes for the preparation of glucosamine sulfate metal chlorides | |
JPH0548227B2 (en) | ||
US8183408B2 (en) | Process for production of N-carbamoyl-tert-leucine | |
ES2188816T5 (en) | PROCEDURE TO PREPARE 4,6-DIHYDROXIPIRIMIDINE. | |
JPH05194337A (en) | Process for producing alpha-amino acid, p-hydroxyphenyl- glycine, amino acid ester and amino acid amide | |
JPH0524899B2 (en) | ||
JPH0451552B2 (en) | ||
US4672127A (en) | Process for production of hydantoin derivatives | |
KR20120101553A (en) | Process for the preparation of thyroid hormones and salts thereof | |
JPH0451551B2 (en) | ||
EP0156582B1 (en) | Process for the preparation of dl-beta-aryl amino acids | |
US4334087A (en) | Process for preparing α-ketocarboxylic acids | |
IE62410B1 (en) | Process for the resolution of threo-3-[(2-aminophenyl)-thio]-2-hydroxy-3-(4-Methoxy- phenyl) propionic acid | |
JP3082006B2 (en) | Method for producing 2-alkylthio-4,6-dihydroxypyrimidine | |
JP3264533B2 (en) | Method for producing benzophenone derivative | |
SU1736337A3 (en) | Method for synthesis of [@@@-(tert-butylaminomethyl)-3,4-dichlorobenzyl]- thioacetamide or its salts | |
US5591889A (en) | Method for the synthesis of trisodium phosphonoformate hexahydrate | |
US4476306A (en) | Method of preparing 2,4-dihydroxypyrimidine | |
JPH0778052B2 (en) | Optical resolution method of DL-pantolactone | |
EP1963309B1 (en) | Method for producing metal salts of losartan | |
JPH08109152A (en) | Production of phenylpyruvic acid derivative | |
JPH0524903B2 (en) | ||
JPS6067465A (en) | Production of imidazole | |
US6437181B1 (en) | Method for producing (S,S)-N,N′-ethylenediaminedisuccinic acid, analogous compounds or salts thereof | |
US7273947B1 (en) | Method for reducing 3-dimethylamnio-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |